Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center
IntroductionMedullary thyroid carcinoma (MTC) is a rare cancer that accounts for 5% of thyroid cancers. Serum calcitonin is a good biomarker for MTC, which is used for diagnosis, prognosis, and monitoring of recurrence. Calcitonin-negative MTC (CNMTC) is rare but confounds diagnostic and prognostic...
Guardado en:
Autores principales: | Sun Jung Kim, Hyeok Jun Yun, Su-Jin Shin, Yong Sang Lee, Hang-Seok Chang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/41cdf81c328440539e5ec3899b368748 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A case report of simultaneous medullary and papillary carcinoma of thyroid
por: Ziaolhagh Reza, et al.
Publicado: (2021) -
The Prediction of Metastases of Lateral Cervical Lymph Node in Medullary Thyroid Carcinoma
por: Tian-Han Zhou, et al.
Publicado: (2021) -
Somatic Mutations in Exons 10, 11, and 16 of the RET Protooncogene in Medullary Thyroid Carcinoma Patients
por: Elham Shakiba, et al.
Publicado: (2020) -
Active Surveillance in <i>RET</i> Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia
por: Alessandro Prete, et al.
Publicado: (2021) -
Principles of medullary thyroid cancer staging according to AJCC TNM 8th edition
por: O.R Duda, et al.
Publicado: (2021)